ReP USP - Resultado da busca

Artigo de periodico
Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli (2022)
Abichabki, Nathália de Lima Martins ; Zacharias, Luísa Vieira; Moreira, Natália Columbaro; Bellíssimo-Rodrigues, Fernando; Moreira, Fernanda L.; Benzi, Jhohann Richard de Lima ; Ogasawara, Tânia Mara Casare; Ferreira, Joseane Cristina; Ribeiro, Camila M.; Pavan, Fernando R.; Pereira, Leonardo Régis Leira; Brancini, Guilherme Thomaz Pereira; Braga, Gilberto Ubida Leite; Zuardi, Antonio Waldo; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Lanchote, Vera Lucia ; Cantón, Rafael; Darini, Ana Lúcia da Costa ; Andrade, Leonardo Neves de
Source: Scientific Reports. Unidades: FMRP, FCFRP
Subjects: CANABINOIDES, REPOSICIONAMENTO DE FÁRMACOS, RESISTÊNCIA MICROBIANA ÀS DROGAS, SINERGISMO DE DROGAS, TESTES DE SENSIBILIDADE MICROBIANA, BACTÉRIAS GRAM-NEGATIVAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ABICHABKI, Nathália de Lima Martins et al. Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli. Scientific Reports, v. 12, p. 1-15, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41598-022-10393-8. Acesso em: 03 ago. 2024.
APA
Abichabki, N. de L. M., Zacharias, L. V., Moreira, N. C., Bellíssimo-Rodrigues, F., Moreira, F. L., Benzi, J. R. de L., et al. (2022). Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli. Scientific Reports, 12, 1-15. doi:10.1038/s41598-022-10393-8
NLM
Abichabki N de LM, Zacharias LV, Moreira NC, Bellíssimo-Rodrigues F, Moreira FL, Benzi JR de L, Ogasawara TMC, Ferreira JC, Ribeiro CM, Pavan FR, Pereira LRL, Brancini GTP, Braga GUL, Zuardi AW, Hallak JEC, Crippa JA de S, Lanchote VL, Cantón R, Darini AL da C, Andrade LN de. Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli [Internet]. Scientific Reports. 2022 ; 12 1-15.[citado 2024 ago. 03 ] Available from: https://doi.org/10.1038/s41598-022-10393-8
Vancouver
Abichabki N de LM, Zacharias LV, Moreira NC, Bellíssimo-Rodrigues F, Moreira FL, Benzi JR de L, Ogasawara TMC, Ferreira JC, Ribeiro CM, Pavan FR, Pereira LRL, Brancini GTP, Braga GUL, Zuardi AW, Hallak JEC, Crippa JA de S, Lanchote VL, Cantón R, Darini AL da C, Andrade LN de. Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli [Internet]. Scientific Reports. 2022 ; 12 1-15.[citado 2024 ago. 03 ] Available from: https://doi.org/10.1038/s41598-022-10393-8
Artigo de periodico
Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze (2022)
Fabris, Débora; Carvalho, Milene Cristina de ; Brandão, Marcus Lira ; Prado, Wiliam Alves do; Zuardi, Antônio Waldo ; Crippa, José Alexandre de Souza ; Oliveira, Amanda R. de; Lovick, Thelma A.; Genaro, Karina
Source: Journal of Psychopharmacology. Unidades: FMRP, FFCLRP
Subjects: ANSIEDADE, ANTIDEPRESSIVOS, FARMACOTERAPIA, CANABINOIDES, DIFERENÇAS SEXUAIS ANIMAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FABRIS, Débora et al. Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze. Journal of Psychopharmacology, v. 36, n. 12, p. 1371-1383, 2022Tradução . . Disponível em: https://doi.org/10.1177/02698811221125440. Acesso em: 03 ago. 2024.
APA
Fabris, D., Carvalho, M. C. de, Brandão, M. L., Prado, W. A. do, Zuardi, A. W., Crippa, J. A. de S., et al. (2022). Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze. Journal of Psychopharmacology, 36( 12), 1371-1383. doi:10.1177/02698811221125440
NLM
Fabris D, Carvalho MC de, Brandão ML, Prado WA do, Zuardi AW, Crippa JA de S, Oliveira AR de, Lovick TA, Genaro K. Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze [Internet]. Journal of Psychopharmacology. 2022 ; 36( 12): 1371-1383.[citado 2024 ago. 03 ] Available from: https://doi.org/10.1177/02698811221125440
Vancouver
Fabris D, Carvalho MC de, Brandão ML, Prado WA do, Zuardi AW, Crippa JA de S, Oliveira AR de, Lovick TA, Genaro K. Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze [Internet]. Journal of Psychopharmacology. 2022 ; 36( 12): 1371-1383.[citado 2024 ago. 03 ] Available from: https://doi.org/10.1177/02698811221125440
Artigo de periodico
Cannabidiol effectively reverses mechanical and thermal allodynia, hyperalgesia, and anxious behaviors in a neuropathic pain model: possible role of CB1 and TRPV1 receptors (2021)
Cardoso, Gleice Kelli Ribeiro da Silva; Lopes, Willian Lazarini; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Zuardi, Antonio Waldo; Garcia-Cairasco, Norberto ; Leite-Panissi, Christie Ramos Andrade
Source: Neuropharmacology. Unidades: FMRP, FFCLRP
Subjects: AMÍGDALA DO CEREBELO, CANABINOIDES, DOR CRÔNICA, HIPOCAMPO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARDOSO, Gleice Kelli Ribeiro da Silva et al. Cannabidiol effectively reverses mechanical and thermal allodynia, hyperalgesia, and anxious behaviors in a neuropathic pain model: possible role of CB1 and TRPV1 receptors. Neuropharmacology, v. 197, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2021.108712. Acesso em: 03 ago. 2024.
APA
Cardoso, G. K. R. da S., Lopes, W. L., Hallak, J. E. C., Crippa, J. A. de S., Zuardi, A. W., Garcia-Cairasco, N., & Leite-Panissi, C. R. A. (2021). Cannabidiol effectively reverses mechanical and thermal allodynia, hyperalgesia, and anxious behaviors in a neuropathic pain model: possible role of CB1 and TRPV1 receptors. Neuropharmacology, 197. doi:10.1016/j.neuropharm.2021.108712
NLM
Cardoso GKR da S, Lopes WL, Hallak JEC, Crippa JA de S, Zuardi AW, Garcia-Cairasco N, Leite-Panissi CRA. Cannabidiol effectively reverses mechanical and thermal allodynia, hyperalgesia, and anxious behaviors in a neuropathic pain model: possible role of CB1 and TRPV1 receptors [Internet]. Neuropharmacology. 2021 ; 197[citado 2024 ago. 03 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108712
Vancouver
Cardoso GKR da S, Lopes WL, Hallak JEC, Crippa JA de S, Zuardi AW, Garcia-Cairasco N, Leite-Panissi CRA. Cannabidiol effectively reverses mechanical and thermal allodynia, hyperalgesia, and anxious behaviors in a neuropathic pain model: possible role of CB1 and TRPV1 receptors [Internet]. Neuropharmacology. 2021 ; 197[citado 2024 ago. 03 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108712
Trabalho de evento-resumo periodico
Neuroprotective effects of cannabidiol in human neural cell lines infected with SARS-CoV-2 (2021)
Ferreira, Rafael Rinaldi; Costa, Karla Cristinne Mancini ; Santos, Isabela Pires dos; Scomparin, Davi Silveira; Scarante, Franciele Franco ; Martins Júnior, Ronaldo Bragança; Batah, Sabrina Setembre ; Fabro, Alexandre Todorovic ; Guedes, Isabella; Dardenne, Laurent; Guimarães, Francisco Silveira ; Hallak, Jaime Eduardo Cecilio ; Zuardi, Antonio Waldo; Crippa, José Alexandre de Souza ; Arruda Neto, Eurico; Campos, Alline Cristina de
Source: Neuropsychopharmacology. Conference titles: ACNP Annual Meeting. Unidades: FCFRP, FMRP, ESALQ
Subjects: CANABINOIDES, COVID-19, VIROSES, DOENÇAS DO SISTEMA NERVOSO, CANABINOIDES, COVID-19, VIROSES, DOENÇAS DO SISTEMA NERVOSO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Rafael Rinaldi et al. Neuroprotective effects of cannabidiol in human neural cell lines infected with SARS-CoV-2. Neuropsychopharmacology. London: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://www.nature.com/articles/s41386-021-01237-6#Sec289. Acesso em: 03 ago. 2024. , 2021
APA
Ferreira, R. R., Costa, K. C. M., Santos, I. P. dos, Scomparin, D. S., Scarante, F. F., Martins Júnior, R. B., et al. (2021). Neuroprotective effects of cannabidiol in human neural cell lines infected with SARS-CoV-2. Neuropsychopharmacology. London: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Recuperado de https://www.nature.com/articles/s41386-021-01237-6#Sec289
NLM
Ferreira RR, Costa KCM, Santos IP dos, Scomparin DS, Scarante FF, Martins Júnior RB, Batah SS, Fabro AT, Guedes I, Dardenne L, Guimarães FS, Hallak JEC, Zuardi AW, Crippa JA de S, Arruda Neto E, Campos AC de. Neuroprotective effects of cannabidiol in human neural cell lines infected with SARS-CoV-2 [Internet]. Neuropsychopharmacology. 2021 ; 46( suppl. 1): 301-302.[citado 2024 ago. 03 ] Available from: https://www.nature.com/articles/s41386-021-01237-6#Sec289
Vancouver
Ferreira RR, Costa KCM, Santos IP dos, Scomparin DS, Scarante FF, Martins Júnior RB, Batah SS, Fabro AT, Guedes I, Dardenne L, Guimarães FS, Hallak JEC, Zuardi AW, Crippa JA de S, Arruda Neto E, Campos AC de. Neuroprotective effects of cannabidiol in human neural cell lines infected with SARS-CoV-2 [Internet]. Neuropsychopharmacology. 2021 ; 46( suppl. 1): 301-302.[citado 2024 ago. 03 ] Available from: https://www.nature.com/articles/s41386-021-01237-6#Sec289
Artigo de periodico
A single oral dose of cannabidiol did not reduce upper limb tremor in patients with essential tremor (2021)
Alencar, Stela Santos de; Crippa, José Alexandre de Souza ; Brito, Manuelina C. M.; Pimentel, Angela Vieira; Hallak, Jaime Eduardo Cecilio ; Tumas, Vitor
Source: Parkinsonism & Related Disorders. Unidade: FMRP
Subjects: CANABINOIDES, CANABINOIDES, TREMOR, MÉTODO DUPLO-CEGO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALENCAR, Stela Santos de et al. A single oral dose of cannabidiol did not reduce upper limb tremor in patients with essential tremor. Parkinsonism & Related Disorders, v. 83, p. 37-40, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.parkreldis.2021.01.001. Acesso em: 03 ago. 2024.
APA
Alencar, S. S. de, Crippa, J. A. de S., Brito, M. C. M., Pimentel, A. V., Hallak, J. E. C., & Tumas, V. (2021). A single oral dose of cannabidiol did not reduce upper limb tremor in patients with essential tremor. Parkinsonism & Related Disorders, 83, 37-40. doi:10.1016/j.parkreldis.2021.01.001
NLM
Alencar SS de, Crippa JA de S, Brito MCM, Pimentel AV, Hallak JEC, Tumas V. A single oral dose of cannabidiol did not reduce upper limb tremor in patients with essential tremor [Internet]. Parkinsonism & Related Disorders. 2021 ; 83 37-40.[citado 2024 ago. 03 ] Available from: https://doi.org/10.1016/j.parkreldis.2021.01.001
Vancouver
Alencar SS de, Crippa JA de S, Brito MCM, Pimentel AV, Hallak JEC, Tumas V. A single oral dose of cannabidiol did not reduce upper limb tremor in patients with essential tremor [Internet]. Parkinsonism & Related Disorders. 2021 ; 83 37-40.[citado 2024 ago. 03 ] Available from: https://doi.org/10.1016/j.parkreldis.2021.01.001
Artigo de periodico
Cannabidiol induces autophagy via ERK1/2 activation in neural cells (2021)
Vrechi, Talita Aparecida de Moraes; Leão, Anderson H. F. F.; Morais, Ingrid B. M.; Abilio, Vanessa Costhek; Zuardi, Antonio Waldo; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Bincoletto, Cláudia; Ureshino, Rodrigo P.; Smaili, Soraya Soubhi; Pereira, Gustavo José da Silva
Source: Scientific Reports. Unidade: FMRP
Subjects: CANABINOIDES, LINHAGEM CELULAR, DOENÇAS NEURODEGENERATIVAS, NEUROBLASTOMA, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VRECHI, Talita Aparecida de Moraes et al. Cannabidiol induces autophagy via ERK1/2 activation in neural cells. Scientific Reports, v. 11, n. 1, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41598-021-84879-2. Acesso em: 03 ago. 2024.
APA
Vrechi, T. A. de M., Leão, A. H. F. F., Morais, I. B. M., Abilio, V. C., Zuardi, A. W., Hallak, J. E. C., et al. (2021). Cannabidiol induces autophagy via ERK1/2 activation in neural cells. Scientific Reports, 11( 1). doi:10.1038/s41598-021-84879-2
NLM
Vrechi TA de M, Leão AHFF, Morais IBM, Abilio VC, Zuardi AW, Hallak JEC, Crippa JA de S, Bincoletto C, Ureshino RP, Smaili SS, Pereira GJ da S. Cannabidiol induces autophagy via ERK1/2 activation in neural cells [Internet]. Scientific Reports. 2021 ; 11( 1):[citado 2024 ago. 03 ] Available from: https://doi.org/10.1038/s41598-021-84879-2
Vancouver
Vrechi TA de M, Leão AHFF, Morais IBM, Abilio VC, Zuardi AW, Hallak JEC, Crippa JA de S, Bincoletto C, Ureshino RP, Smaili SS, Pereira GJ da S. Cannabidiol induces autophagy via ERK1/2 activation in neural cells [Internet]. Scientific Reports. 2021 ; 11( 1):[citado 2024 ago. 03 ] Available from: https://doi.org/10.1038/s41598-021-84879-2
Artigo de periodico-carta/editorial
Cannabinoids for the treatment of mental disorders [Carta] (2020)
Crippa, José Alexandre de Souza ; Osório, Flávia de Lima ; Hallak, Jaime Eduardo Cecilio ; Guimarães, Francisco Silveira ; Zuardi, Antonio Waldo
Source: The Lancet Psychiatry. Unidade: FMRP
Subjects: CANABINOIDES, ARTIGO CIENTÍFICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRIPPA, José Alexandre de Souza et al. Cannabinoids for the treatment of mental disorders [Carta]. The Lancet Psychiatry. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/S2215-0366(19)30516-4. Acesso em: 03 ago. 2024. , 2020
APA
Crippa, J. A. de S., Osório, F. de L., Hallak, J. E. C., Guimarães, F. S., & Zuardi, A. W. (2020). Cannabinoids for the treatment of mental disorders [Carta]. The Lancet Psychiatry. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/S2215-0366(19)30516-4
NLM
Crippa JA de S, Osório F de L, Hallak JEC, Guimarães FS, Zuardi AW. Cannabinoids for the treatment of mental disorders [Carta] [Internet]. The Lancet Psychiatry. 2020 ; 7( 2): 125-126.[citado 2024 ago. 03 ] Available from: https://doi.org/10.1016/S2215-0366(19)30516-4
Vancouver
Crippa JA de S, Osório F de L, Hallak JEC, Guimarães FS, Zuardi AW. Cannabinoids for the treatment of mental disorders [Carta] [Internet]. The Lancet Psychiatry. 2020 ; 7( 2): 125-126.[citado 2024 ago. 03 ] Available from: https://doi.org/10.1016/S2215-0366(19)30516-4
Artigo de periodico
Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials (2020)
Santos, Rafael Guimarães dos ; Guimarães, Francisco Silveira ; Crippa, José Alexandre de Souza ; Hallak, Jaime Eduardo Cecilio ; Rossi, Giordano Novak; Rocha, Juliana Mendes; Zuardi, Antonio Waldo
Source: Expert Opinion on Drug Metabolism & Toxicology. Unidade: FMRP
Subjects: CANABINOIDES, INTERAÇÃO DE DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Rafael Guimarães dos et al. Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials. Expert Opinion on Drug Metabolism & Toxicology, v. 16, n. 6, p. 517-526, 2020Tradução . . Disponível em: https://doi.org/10.1080/17425255.2020.1754793. Acesso em: 03 ago. 2024.
APA
Santos, R. G. dos, Guimarães, F. S., Crippa, J. A. de S., Hallak, J. E. C., Rossi, G. N., Rocha, J. M., & Zuardi, A. W. (2020). Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials. Expert Opinion on Drug Metabolism & Toxicology, 16( 6), 517-526. doi:10.1080/17425255.2020.1754793
NLM
Santos RG dos, Guimarães FS, Crippa JA de S, Hallak JEC, Rossi GN, Rocha JM, Zuardi AW. Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials [Internet]. Expert Opinion on Drug Metabolism & Toxicology. 2020 ; 16( 6): 517-526.[citado 2024 ago. 03 ] Available from: https://doi.org/10.1080/17425255.2020.1754793
Vancouver
Santos RG dos, Guimarães FS, Crippa JA de S, Hallak JEC, Rossi GN, Rocha JM, Zuardi AW. Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials [Internet]. Expert Opinion on Drug Metabolism & Toxicology. 2020 ; 16( 6): 517-526.[citado 2024 ago. 03 ] Available from: https://doi.org/10.1080/17425255.2020.1754793
Artigo de periodico
Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature (2019)
Rocha, Juliana M.; Osório, Flávia de Lima ; Crippa, José Alexandre de Souza ; Bouso, José Carlos; Rossi, Giordano Novak ; Hallak, Jaime Eduardo Cecilio ; Santos, Rafael Guimarães dos
Source: Therapeutic Advances in Psychopharmacology. Unidade: FMRP
Subjects: ALUCINOGÊNICOS, EXPRESSÃO CORPORAL, FACE, EMOÇÕES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHA, Juliana M. et al. Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature. Therapeutic Advances in Psychopharmacology, v. 9, p. 1-11, 2019Tradução . . Disponível em: https://doi.org/10.1177/2045125319845774. Acesso em: 03 ago. 2024.
APA
Rocha, J. M., Osório, F. de L., Crippa, J. A. de S., Bouso, J. C., Rossi, G. N., Hallak, J. E. C., & Santos, R. G. dos. (2019). Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature. Therapeutic Advances in Psychopharmacology, 9, 1-11. doi:10.1177/2045125319845774
NLM
Rocha JM, Osório F de L, Crippa JA de S, Bouso JC, Rossi GN, Hallak JEC, Santos RG dos. Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature [Internet]. Therapeutic Advances in Psychopharmacology. 2019 ; 9 1-11.[citado 2024 ago. 03 ] Available from: https://doi.org/10.1177/2045125319845774
Vancouver
Rocha JM, Osório F de L, Crippa JA de S, Bouso JC, Rossi GN, Hallak JEC, Santos RG dos. Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature [Internet]. Therapeutic Advances in Psychopharmacology. 2019 ; 9 1-11.[citado 2024 ago. 03 ] Available from: https://doi.org/10.1177/2045125319845774
Artigo de periodico
Intraperitoneal cannabidiol attenuates neonatal germinal matrix hemorrhage-induced neuroinflamation and perilesional apoptosis (2019)
Almeida, Timóteo Abrantes de Lacerda ; Santos, Marcelo Volpon ; Lopes, Luiza da Silva ; Goel, Gunjan; Freitas, Renato Leonardo de ; Medeiros, Priscila de; Crippa, José Alexandre de Souza ; Machado, Hélio Rubens
Source: Neurological Research. Unidade: FMRP
Subjects: APOPTOSE, CANABINOIDES, HEMORRAGIA, INFLAMAÇÃO, IMUNOHISTOQUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Timóteo Abrantes de Lacerda et al. Intraperitoneal cannabidiol attenuates neonatal germinal matrix hemorrhage-induced neuroinflamation and perilesional apoptosis. Neurological Research, v. 41, n. 11, p. 980-990, 2019Tradução . . Disponível em: https://doi.org/10.1080/01616412.2019.1651487. Acesso em: 03 ago. 2024.
APA
Almeida, T. A. de L., Santos, M. V., Lopes, L. da S., Goel, G., Freitas, R. L. de, Medeiros, P. de, et al. (2019). Intraperitoneal cannabidiol attenuates neonatal germinal matrix hemorrhage-induced neuroinflamation and perilesional apoptosis. Neurological Research, 41( 11), 980-990. doi:10.1080/01616412.2019.1651487
NLM
Almeida TA de L, Santos MV, Lopes L da S, Goel G, Freitas RL de, Medeiros P de, Crippa JA de S, Machado HR. Intraperitoneal cannabidiol attenuates neonatal germinal matrix hemorrhage-induced neuroinflamation and perilesional apoptosis [Internet]. Neurological Research. 2019 ; 41( 11): 980-990.[citado 2024 ago. 03 ] Available from: https://doi.org/10.1080/01616412.2019.1651487
Vancouver
Almeida TA de L, Santos MV, Lopes L da S, Goel G, Freitas RL de, Medeiros P de, Crippa JA de S, Machado HR. Intraperitoneal cannabidiol attenuates neonatal germinal matrix hemorrhage-induced neuroinflamation and perilesional apoptosis [Internet]. Neurological Research. 2019 ; 41( 11): 980-990.[citado 2024 ago. 03 ] Available from: https://doi.org/10.1080/01616412.2019.1651487
Artigo de periodico
Role of the endocannabinoid and endovanilloid systems in an animal model of schizophrenia-related emotional processing/cognitive deficit (2019)
Almeida, Valéria; Levin, Raquel; Peres, Fernanda Fiel; Suiama, Mayra Akimi; Vendramini, Ana Maria; Santos, Camila Maurício; Silva, Neide Derci da; Zuardi, Antônio Waldo ; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Abilio, Vanessa Costhek
Source: Neuropharmacology. Unidade: FMRP
Subjects: ESQUIZOFRENIA, CANABINOIDES, COGNIÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Valéria et al. Role of the endocannabinoid and endovanilloid systems in an animal model of schizophrenia-related emotional processing/cognitive deficit. Neuropharmacology, v. 155, p. 44-53, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2019.05.015. Acesso em: 03 ago. 2024.
APA
Almeida, V., Levin, R., Peres, F. F., Suiama, M. A., Vendramini, A. M., Santos, C. M., et al. (2019). Role of the endocannabinoid and endovanilloid systems in an animal model of schizophrenia-related emotional processing/cognitive deficit. Neuropharmacology, 155, 44-53. doi:10.1016/j.neuropharm.2019.05.015
NLM
Almeida V, Levin R, Peres FF, Suiama MA, Vendramini AM, Santos CM, Silva ND da, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Role of the endocannabinoid and endovanilloid systems in an animal model of schizophrenia-related emotional processing/cognitive deficit [Internet]. Neuropharmacology. 2019 ; 155 44-53.[citado 2024 ago. 03 ] Available from: https://doi.org/10.1016/j.neuropharm.2019.05.015
Vancouver
Almeida V, Levin R, Peres FF, Suiama MA, Vendramini AM, Santos CM, Silva ND da, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Role of the endocannabinoid and endovanilloid systems in an animal model of schizophrenia-related emotional processing/cognitive deficit [Internet]. Neuropharmacology. 2019 ; 155 44-53.[citado 2024 ago. 03 ] Available from: https://doi.org/10.1016/j.neuropharm.2019.05.015
Artigo de periodico
Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: the SHR strain (2018)
Diana, Mariana C.; Peres, Fernanda F.; Justi, Veronica; Bressan, Rodrigo A.; Lacerda, Acioly L. T.; Crippa, José Alexandre de Souza; Hallak, Jaime Eduardo Cecílio; Abilio, Vanesssa Costhek
Source: CNS Neuroscience and Therapeutics. Unidade: FMRP
Subjects: ESQUIZOFRENIA, RATOS, PREVENÇÃO DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DIANA, Mariana C. et al. Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: the SHR strain. CNS Neuroscience and Therapeutics, v. 24, n. 7, p. 624-632, 2018Tradução . . Disponível em: https://doi.org/10.1111/cns.12852. Acesso em: 03 ago. 2024.
APA
Diana, M. C., Peres, F. F., Justi, V., Bressan, R. A., Lacerda, A. L. T., Crippa, J. A. de S., et al. (2018). Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: the SHR strain. CNS Neuroscience and Therapeutics, 24( 7), 624-632. doi:10.1111/cns.12852
NLM
Diana MC, Peres FF, Justi V, Bressan RA, Lacerda ALT, Crippa JA de S, Hallak JEC, Abilio VC. Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: the SHR strain [Internet]. CNS Neuroscience and Therapeutics. 2018 ; 24( 7): 624-632.[citado 2024 ago. 03 ] Available from: https://doi.org/10.1111/cns.12852
Vancouver
Diana MC, Peres FF, Justi V, Bressan RA, Lacerda ALT, Crippa JA de S, Hallak JEC, Abilio VC. Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: the SHR strain [Internet]. CNS Neuroscience and Therapeutics. 2018 ; 24( 7): 624-632.[citado 2024 ago. 03 ] Available from: https://doi.org/10.1111/cns.12852
Artigo de periodico
Clinical issues in cannabis use (2018)
Bonomo, Yvonne; Souza, José Diogo S.; Jackson, Aidan; Crippa, José Alexandre de Souza; Solowij, Nadia
Source: British Journal of Clinical Pharmacology. Unidade: FMRP
Subjects: ANTIRRETROVIRAIS, SANGUE, CORDÃO UMBILICAL, VÍRUS, GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONOMO, Yvonne et al. Clinical issues in cannabis use. British Journal of Clinical Pharmacology, v. 84, n. 11, p. 2495-2498, 2018Tradução . . Disponível em: https://doi.org/10.1111/bcp.13703. Acesso em: 03 ago. 2024.
APA
Bonomo, Y., Souza, J. D. S., Jackson, A., Crippa, J. A. de S., & Solowij, N. (2018). Clinical issues in cannabis use. British Journal of Clinical Pharmacology, 84( 11), 2495-2498. doi:10.1111/bcp.13703
NLM
Bonomo Y, Souza JDS, Jackson A, Crippa JA de S, Solowij N. Clinical issues in cannabis use [Internet]. British Journal of Clinical Pharmacology. 2018 ; 84( 11): 2495-2498.[citado 2024 ago. 03 ] Available from: https://doi.org/10.1111/bcp.13703
Vancouver
Bonomo Y, Souza JDS, Jackson A, Crippa JA de S, Solowij N. Clinical issues in cannabis use [Internet]. British Journal of Clinical Pharmacology. 2018 ; 84( 11): 2495-2498.[citado 2024 ago. 03 ] Available from: https://doi.org/10.1111/bcp.13703
Parte de monografia/livro
Cannabidiol and neuroprotection: evidence from preclinical studies (2017)
Schröder, N.; Silva, V. K.; Hallak, Jaime Eduardo Cecilio ; Zuardi, Antonio Waldo; Crippa, José Alexandre de Souza
Source: Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment. Unidade: FMRP
Subjects: CANNABIS, ANTIOXIDANTES, DOENÇA DE ALZHEIMER, ANÓXIA, ISQUEMIA, FERRO, MODELOS ANIMAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHRÖDER, N. et al. Cannabidiol and neuroprotection: evidence from preclinical studies. Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment. Tradução . London: Elsevier, 2017. p. 1143 . Disponível em: https://doi.org/10.1016/B978-0-12-800756-3.00095-8. Acesso em: 03 ago. 2024.
APA
Schröder, N., Silva, V. K., Hallak, J. E. C., Zuardi, A. W., & Crippa, J. A. de S. (2017). Cannabidiol and neuroprotection: evidence from preclinical studies. In Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment (p. 1143 ). London: Elsevier. doi:10.1016/B978-0-12-800756-3.00095-8
NLM
Schröder N, Silva VK, Hallak JEC, Zuardi AW, Crippa JA de S. Cannabidiol and neuroprotection: evidence from preclinical studies [Internet]. In: Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment. London: Elsevier; 2017. p. 1143 .[citado 2024 ago. 03 ] Available from: https://doi.org/10.1016/B978-0-12-800756-3.00095-8
Vancouver
Schröder N, Silva VK, Hallak JEC, Zuardi AW, Crippa JA de S. Cannabidiol and neuroprotection: evidence from preclinical studies [Internet]. In: Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment. London: Elsevier; 2017. p. 1143 .[citado 2024 ago. 03 ] Available from: https://doi.org/10.1016/B978-0-12-800756-3.00095-8
Parte de monografia/livro
Cannabidiol for the treatment of drug use disorders (2017)
Santos, Rafael Guimarães dos ; Hallak, Jaime Eduardo Cecilio ; Zuardi, Antonio Waldo; Crippa, José Alexandre de Souza
Source: Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment. Unidade: FMRP
Subjects: TRANSTORNOS PSICÓTICOS, DROGAS DE ABUSO, MACONHA, CANNABIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Rafael Guimarães dos et al. Cannabidiol for the treatment of drug use disorders. Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment. Tradução . London: Elsevier, 2017. p. 1143 . Disponível em: https://doi.org/10.1016/B978-0-12-800756-3.00113-7. Acesso em: 03 ago. 2024.
APA
Santos, R. G. dos, Hallak, J. E. C., Zuardi, A. W., & Crippa, J. A. de S. (2017). Cannabidiol for the treatment of drug use disorders. In Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment (p. 1143 ). London: Elsevier. doi:10.1016/B978-0-12-800756-3.00113-7
NLM
Santos RG dos, Hallak JEC, Zuardi AW, Crippa JA de S. Cannabidiol for the treatment of drug use disorders [Internet]. In: Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment. London: Elsevier; 2017. p. 1143 .[citado 2024 ago. 03 ] Available from: https://doi.org/10.1016/B978-0-12-800756-3.00113-7
Vancouver
Santos RG dos, Hallak JEC, Zuardi AW, Crippa JA de S. Cannabidiol for the treatment of drug use disorders [Internet]. In: Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment. London: Elsevier; 2017. p. 1143 .[citado 2024 ago. 03 ] Available from: https://doi.org/10.1016/B978-0-12-800756-3.00113-7
Artigo de periodico
Psychometric properties of the dimensional anxiety scales for DSM-5 in a Brazilian community sample (2017)
DeSousa, Diogo A.; Moreno, André L.; Osório, Flávia de Lima; Crippa, José Alexandre de Souza; LeBeau, Richard; Manfro, Gisele G.; Salum, Giovanni A.; Koller, Silvia H.
Source: International Journal of Methods in Psychiatric Research. Unidade: FMRP
Subjects: ANSIEDADE, ESCALAS (PSICOMETRIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DESOUSA, Diogo A. et al. Psychometric properties of the dimensional anxiety scales for DSM-5 in a Brazilian community sample. International Journal of Methods in Psychiatric Research, v. 26, n. 3, 2017Tradução . . Disponível em: https://doi.org/10.1002/mpr.1531. Acesso em: 03 ago. 2024.
APA
DeSousa, D. A., Moreno, A. L., Osório, F. de L., Crippa, J. A. de S., LeBeau, R., Manfro, G. G., et al. (2017). Psychometric properties of the dimensional anxiety scales for DSM-5 in a Brazilian community sample. International Journal of Methods in Psychiatric Research, 26( 3). doi:10.1002/mpr.1531
NLM
DeSousa DA, Moreno AL, Osório F de L, Crippa JA de S, LeBeau R, Manfro GG, Salum GA, Koller SH. Psychometric properties of the dimensional anxiety scales for DSM-5 in a Brazilian community sample [Internet]. International Journal of Methods in Psychiatric Research. 2017 ; 26( 3):[citado 2024 ago. 03 ] Available from: https://doi.org/10.1002/mpr.1531
Vancouver
DeSousa DA, Moreno AL, Osório F de L, Crippa JA de S, LeBeau R, Manfro GG, Salum GA, Koller SH. Psychometric properties of the dimensional anxiety scales for DSM-5 in a Brazilian community sample [Internet]. International Journal of Methods in Psychiatric Research. 2017 ; 26( 3):[citado 2024 ago. 03 ] Available from: https://doi.org/10.1002/mpr.1531
Artigo de periodico
Neuroimaging of major depression in Parkinson's disease: cortical thickness, cortical and subcortical volume, and spectroscopy findings (2017)
Chagas, Marcos Hortes Nisihara; Tumas, Vitor; Pena-Pereira, Márcio Alexandre; Machado-de-Sousa, João Paulo; Santos, Antônio Carlos dos; Sanches, Rafael Faria; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza
Source: Journal of Psychiatric Research. Unidade: FMRP
Subjects: NEUROIMAGEM, DOENÇA DE PARKINSON, DEPRESSÃO, ESPECTROSCOPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAGAS, Marcos Hortes Nisihara et al. Neuroimaging of major depression in Parkinson's disease: cortical thickness, cortical and subcortical volume, and spectroscopy findings. Journal of Psychiatric Research, v. 90, p. 40-45, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.jpsychires.2017.02.010. Acesso em: 03 ago. 2024.
APA
Chagas, M. H. N., Tumas, V., Pena-Pereira, M. A., Machado-de-Sousa, J. P., Santos, A. C. dos, Sanches, R. F., et al. (2017). Neuroimaging of major depression in Parkinson's disease: cortical thickness, cortical and subcortical volume, and spectroscopy findings. Journal of Psychiatric Research, 90, 40-45. doi:10.1016/j.jpsychires.2017.02.010
NLM
Chagas MHN, Tumas V, Pena-Pereira MA, Machado-de-Sousa JP, Santos AC dos, Sanches RF, Hallak JEC, Crippa JA de S. Neuroimaging of major depression in Parkinson's disease: cortical thickness, cortical and subcortical volume, and spectroscopy findings [Internet]. Journal of Psychiatric Research. 2017 ; 90 40-45.[citado 2024 ago. 03 ] Available from: https://doi.org/10.1016/j.jpsychires.2017.02.010
Vancouver
Chagas MHN, Tumas V, Pena-Pereira MA, Machado-de-Sousa JP, Santos AC dos, Sanches RF, Hallak JEC, Crippa JA de S. Neuroimaging of major depression in Parkinson's disease: cortical thickness, cortical and subcortical volume, and spectroscopy findings [Internet]. Journal of Psychiatric Research. 2017 ; 90 40-45.[citado 2024 ago. 03 ] Available from: https://doi.org/10.1016/j.jpsychires.2017.02.010
Parte de monografia/livro
Cannabidiol for the treatment of epilepsy: an overview of possible mechanisms of action and preclinical and human studies (2017)
Santos, Rafael Guimarães dos ; Hallak, Jaime Eduardo Cecilio ; Zuardi, Antonio Waldo; Crippa, A. C. de Souza; Crippa, José Alexandre de Souza
Source: Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment. Unidade: FMRP
Subjects: CANNABIS, EPILEPSIA, ANSIEDADE, ANTICONVULSIVANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Rafael Guimarães dos et al. Cannabidiol for the treatment of epilepsy: an overview of possible mechanisms of action and preclinical and human studies. Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment. Tradução . London: Elsevier, 2017. p. 1143 . Disponível em: https://doi.org/10.1016/B978-0-12-800756-3.00094-6. Acesso em: 03 ago. 2024.
APA
Santos, R. G. dos, Hallak, J. E. C., Zuardi, A. W., Crippa, A. C. de S., & Crippa, J. A. de S. (2017). Cannabidiol for the treatment of epilepsy: an overview of possible mechanisms of action and preclinical and human studies. In Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment (p. 1143 ). London: Elsevier. doi:10.1016/B978-0-12-800756-3.00094-6
NLM
Santos RG dos, Hallak JEC, Zuardi AW, Crippa AC de S, Crippa JA de S. Cannabidiol for the treatment of epilepsy: an overview of possible mechanisms of action and preclinical and human studies [Internet]. In: Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment. London: Elsevier; 2017. p. 1143 .[citado 2024 ago. 03 ] Available from: https://doi.org/10.1016/B978-0-12-800756-3.00094-6
Vancouver
Santos RG dos, Hallak JEC, Zuardi AW, Crippa AC de S, Crippa JA de S. Cannabidiol for the treatment of epilepsy: an overview of possible mechanisms of action and preclinical and human studies [Internet]. In: Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment. London: Elsevier; 2017. p. 1143 .[citado 2024 ago. 03 ] Available from: https://doi.org/10.1016/B978-0-12-800756-3.00094-6
Artigo de periodico
Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: a large, international, self-selecting online survey (2017)
Lawn, Will; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza; Santos, Rafael dos; Porffy, Lilla; Barratt, Monica J.; Ferris, Jason A.; Winstock, Adam R.; Morgan, Celia J. A.
Source: Scientific Reports. Unidade: FMRP
Subjects: BEBIDAS, ALUCINOGÊNICOS, ABUSO DE ÁLCOOL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LAWN, Will et al. Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: a large, international, self-selecting online survey. Scientific Reports, v. 7, n. 1, 2017Tradução . . Disponível em: https://doi.org/10.1038/s41598-017-14700-6. Acesso em: 03 ago. 2024.
APA
Lawn, W., Hallak, J. E. C., Crippa, J. A. de S., Santos, R. dos, Porffy, L., Barratt, M. J., et al. (2017). Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: a large, international, self-selecting online survey. Scientific Reports, 7( 1). doi:10.1038/s41598-017-14700-6
NLM
Lawn W, Hallak JEC, Crippa JA de S, Santos R dos, Porffy L, Barratt MJ, Ferris JA, Winstock AR, Morgan CJA. Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: a large, international, self-selecting online survey [Internet]. Scientific Reports. 2017 ; 7( 1):[citado 2024 ago. 03 ] Available from: https://doi.org/10.1038/s41598-017-14700-6
Vancouver
Lawn W, Hallak JEC, Crippa JA de S, Santos R dos, Porffy L, Barratt MJ, Ferris JA, Winstock AR, Morgan CJA. Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: a large, international, self-selecting online survey [Internet]. Scientific Reports. 2017 ; 7( 1):[citado 2024 ago. 03 ] Available from: https://doi.org/10.1038/s41598-017-14700-6
Artigo de periodico
Determination of drugs in plasma samples by high-performance liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring of schizophrenic patients (2016)
Domingues, Diego Soares; Pinto, Mônia Aparecida Lemos; Souza, Israel Donizeti de; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza; Queiroz, Maria Eugênia Costa
Source: Journal of Analytical Toxicology. Unidades: FMRP, FFCLRP
Subjects: CROMATOGRAFIA LÍQUIDA DE ALTA EFICIÊNCIA, ESPECTROMETRIA DE MASSAS, ANTIPSICÓTICOS, ANTIDEPRESSIVOS, ANTICONVULSIVANTES, ANSIOLÍTICOS, PLASMA (AMOSTRA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DOMINGUES, Diego Soares et al. Determination of drugs in plasma samples by high-performance liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring of schizophrenic patients. Journal of Analytical Toxicology, v. 40, n. 1, p. 28-36, 2016Tradução . . Disponível em: https://doi.org/10.1093/jat/bkv107. Acesso em: 03 ago. 2024.
APA
Domingues, D. S., Pinto, M. A. L., Souza, I. D. de, Hallak, J. E. C., Crippa, J. A. de S., & Queiroz, M. E. C. (2016). Determination of drugs in plasma samples by high-performance liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring of schizophrenic patients. Journal of Analytical Toxicology, 40( 1), 28-36. doi:10.1093/jat/bkv107
NLM
Domingues DS, Pinto MAL, Souza ID de, Hallak JEC, Crippa JA de S, Queiroz MEC. Determination of drugs in plasma samples by high-performance liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring of schizophrenic patients [Internet]. Journal of Analytical Toxicology. 2016 ; 40( 1): 28-36.[citado 2024 ago. 03 ] Available from: https://doi.org/10.1093/jat/bkv107
Vancouver
Domingues DS, Pinto MAL, Souza ID de, Hallak JEC, Crippa JA de S, Queiroz MEC. Determination of drugs in plasma samples by high-performance liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring of schizophrenic patients [Internet]. Journal of Analytical Toxicology. 2016 ; 40( 1): 28-36.[citado 2024 ago. 03 ] Available from: https://doi.org/10.1093/jat/bkv107

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration